Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor-Reference-Cited by-同舟云学术

Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor

Published:2017-03 Issue: Volume:4 Page:31-40
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Lilly Cameron L.,Villa Nancy Y.,Lemos de Matos Ana,Ali Haider M.,Dhillon Jess-Karan S.,Hofland Tom,Rahman Masmudur M.,Chan Winnie,Bogen Bjarne,Cogle Christopher,McFadden Grant

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference39 articles.

1. Selective reduction of graft-versus-host disease-mediating human T cells by ex vivo treatment with soluble Fas ligand;Bohana-Kashtan;J. Immunol.,2009

2. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma;Barlogie;Blood,1997

3. High-dose therapy and innovative approaches to treatment of multiple myeloma;Barlogie;Semin. Hematol.,2001

4. Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma;Lendvai;Bone Marrow Transplant.,2015

5. Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity;Cornell;Bone Marrow Transplant.,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic Myxoma virus Increases Autophagy in Multiple Myeloma;Turkish Journal of Hematology;2024-03-04

2. Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives;Journal of Drug Delivery Science and Technology;2024-02

3. Myxoma Virus Combination Therapy Enhances Lenalidomide and Bortezomib Treatments for Multiple Myeloma;Pathogens;2024-01-12

4. Neutrophil mediated drug delivery for targeted glioblastoma therapy: A comprehensive review;Biomedicine & Pharmacotherapy;2022-12

5. Metabolic signatures associated with oncolytic myxoma viral infections;Scientific Reports;2022-07-23